Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Whay Kuang, Chia"'
Autor:
Tira J. Tan, W. X. Gladys Ang, Who-Whong Wang, Hui-Shan Chong, Sze Huey Tan, Rachael Cheong, John Whay-Kuang Chia, Nicholas L. Syn, Wai Ho Shuen, Rebecca Ba, Nivashini Kaliaperumal, Bijin Au, Richard Hopkins, Xinhua Li, Aaron C. Tan, Amanda O. L. Seet, John E. Connolly, Thaschawee Arkachaisri, Valerie Chew, Ahmad bin Mohamed Lajam, Dianyan Guo, Marvin Z. W. Chew, Martin Wasser, Pavanish Kumar, Salvatore Albani, Han Chong Toh
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Ad-sig-hMUC1/ecdCD40L is a recombinant adenovirus vaccine comprising human MUC1 antigen fused to the extracellular domain of the CD40 ligand. Here the authors report the result of a phase I clinical trial of Ad-sig-hMUC1/ecdCD40L in patients with adv
Externí odkaz:
https://doaj.org/article/bc9966f3f06642699fbd9cc02be4f7e3
Autor:
Daphne Day, Han Chong Toh, Raghib Ali, Estelle Mei Jye Foo, John Simes, John Whay Kuang Chia, Eva Segelov
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEThe Asia-Pacific (APAC) region is a major focus for multinational clinical trials, although its cultural, linguistic, economic, and regulatory diversity pose significant challenges for trial conduct, particularly for academic clinical trials.M
Externí odkaz:
https://doaj.org/article/d2e76334fda04eb9bb292a3b55e61b90
Autor:
Eva Segelov, Hans Prenen, Daphne Day, C. Raina Macintyre, Estelle Mei Jye Foo, Raghib Ali, Quanyi Wang, Xiaoting Wei, Gilberto de Lima Lopes, Kefeng Ding, Gong Chen, John Whay Kuang Chia, Han Chong Toh
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 585-588 (2020)
Externí odkaz:
https://doaj.org/article/54db7ec56ed34fa699baf42e80a421a6
Autor:
Mogens H. Claesson, Mai-Britt Zocca, Wen Hsin Koo, Simon Ong, Kian Fong Foo, Siew Wan Hee, Sze Huey Tan, Yatanar Soe, Yee Peng Phoon, Kelly Teo, Li Sun, Pia Kvistborg, Whay Kuang Chia, Who-Whong Wang, Han Chong Toh
Supplementary Data from Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a128b0560ab3af157da1a7ac342aa74
https://doi.org/10.1158/1078-0432.22440432
https://doi.org/10.1158/1078-0432.22440432
Autor:
Mogens H. Claesson, Mai-Britt Zocca, Wen Hsin Koo, Simon Ong, Kian Fong Foo, Siew Wan Hee, Sze Huey Tan, Yatanar Soe, Yee Peng Phoon, Kelly Teo, Li Sun, Pia Kvistborg, Whay Kuang Chia, Who-Whong Wang, Han Chong Toh
Purpose: We evaluated the clinical benefit of an allogeneic melanoma cell lysate (MCL)–pulsed autologous dendritic cell (DC) vaccine in advanced colorectal cancer patients expressing at least one of six MAGE-A antigens overexpressed by the cell lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0053dc32781966b8265ef9c77bd5e5
https://doi.org/10.1158/1078-0432.c.6517761
https://doi.org/10.1158/1078-0432.c.6517761
Autor:
Chuen Seng Tan, John Whay Kuang Chia, Khuan Yew Chow, Wen Yee Chay, Sheow Lei Lim, Jeff Yi-Fu Hwang, Wei-Yen Lim
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Purpose: We investigate ovarian cancer incidence between 1968 and 2012 in Singapore, a multiethnic Asian city state. Methods: Aggregated data of ovarian epithelial cancer numbers and estimated person-years from 1968 to 2012 were obtained from Singapo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cbc7b292ac6f0642d3881b27b32723
http://europepmc.org/articles/PMC7173386
http://europepmc.org/articles/PMC7173386
Autor:
Swee Sung Soon, Whay-Kuang Chia, Mun-ling Sarah Chan, Gwo Fuang Ho, Xiao Jian, Yan Hong Deng, Chuen-Seng Tan, Atul Sharma, Eva Segelov, Shaesta Mehta, Raghib Ali, Han-Chong Toh, Hwee-Lin Wee
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107866 (2014)
Recent observational studies showed that post-operative aspirin use reduces cancer relapse and death in the earliest stages of colorectal cancer. We sought to evaluate the cost-effectiveness of aspirin as an adjuvant therapy in Stage I and II colorec
Externí odkaz:
https://doaj.org/article/bf706f0459944a6ba39222a0ad9b6251
Autor:
Wen-Yee Chay, Sung-Hock Chew, Whee-Sze Ong, Inny Busmanis, Xinyun Li, Sharyl Thung, Lynette Ngo, Sheow-Lei Lim, Yong-Kuei Lim, Yin-Nin Chia, Elisa Koh, Cindy Pang, Lay-Tin Soh, Jin Wang, Tew-Hong Ho, Sun-Kuie Tay, Soo-Kim Lim-Tan, Kiat-Hon Lim, John Whay-Kuang Chia, Liang-Kee Goh
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61565 (2013)
Mucinous epithelial ovarian cancer has a poor prognosis in the advanced stages and responds poorly to conventional chemotherapy. We aim to elucidate the clinicopathological factors and incidence of HER2 expression of this cancer in a large Asian retr
Externí odkaz:
https://doaj.org/article/ccc75852edbd4af88b50cfb78610698c
Autor:
Shuting Han, Michael Podinger, Chit Lai Chee, John E. Connolly, Rujun Guan, Richard Hopkins, Joseph Wee, Qianting Ching, Wenwei Xiang, Whay-Kuang Chia, Alexander Lezhava, Veonice Bijin Au, Timothy Shuen, Damien Marlier, Lynn Xue Wu, Joanna Ng, Axel Chu, Han Chong Toh, Rachael Cheong, Who-Whong Wang, Bernett Lee
Publikováno v:
Molecular Therapy
Advanced, late-stage Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (NPC) is incurable, and its treatment remains a clinical and therapeutic challenge. Results from a phase II clinical trial in advanced NPC patients employing a combined c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::396566b4ebe7436113b8ecbcd9dc5de7
https://pubmed.ncbi.nlm.nih.gov/33038324
https://pubmed.ncbi.nlm.nih.gov/33038324
Autor:
Hans Prenen, Han Chong Toh, Daphne Day, John Whay Kuang Chia, Raghib Ali, Kefeng Ding, Eva Segelov, Gilberto Lopes, Quanyi Wang, Estelle Mei Jye Foo, Xiaoting Wei, Gong Chen, C. Raina MacIntyre
Publikováno v:
JCO Global Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a2d2af3e564dc87d3bcabcdafc20ff
https://repository.uantwerpen.be/docstore/d:irua:4924
https://repository.uantwerpen.be/docstore/d:irua:4924